Home > Publications database > Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures. > print

001     304989
005     20251005022933.0
024 7 _ |a 10.1002/ctm2.70487
|2 doi
024 7 _ |a pmid:40999586
|2 pmid
024 7 _ |a pmc:PMC12463705
|2 pmc
024 7 _ |a altmetric:181716917
|2 altmetric
037 _ _ |a DKFZ-2025-01980
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Valous, Nektarios
|0 P:(DE-He78)01ddf9bd69d91bd4b1dbef36f9427f36
|b 0
|e First author
|u dkfz
245 _ _ |a Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures.
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1759230669_31256
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Raman spectroscopy is a versatile analytical technique for highly specific molecular characterisation of cells, biofluids and tissues. Confocal Raman microspectroscopy combines optical microscopy with Raman spectroscopy to spatially resolve biochemical changes in tissue samples. This work focuses on research articles that utilise confocal Raman microspectroscopy in human or murine tissue sections for identifying disease-linked spectra-pathological features. For scientists and clinicians who seek ideas in incorporating confocal Raman microspectroscopy into their experimental workflows, this piece provides a curated selection of studies (spanning cancer and cardiovascular diseases) that highlight key spectroscopic and biomedical insights. The lack of standardisation and the fragmentation of research protocols are major challenges that limit study reproducibility and prevent systematic cross-validation. Moving forward, confocal Raman microspectroscopy, coupled with robust computational approaches, will continue to detect disease-specific spatiotemporal biomolecular signatures, and integration with complementary imaging or omics methods will keep enhancing its ability to analyse complex biological systems and uncover disease progression mechanisms. KEY POINTS: Confocal Raman microspectroscopy enables spatially resolved tissue characterisation and reveals disease-linked spectra-pathological features. Key challenges limit clinical translation, for example, lack of standardisation and insufficient reference spectral databases. Future research progress depends on interdisciplinary collaboration, robust computational methods and integration with complementary imaging or omics technologies for enhanced disease characterisation.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Raman microscopy
|2 Other
650 _ 7 |a biochemical imaging
|2 Other
650 _ 7 |a biophotonics
|2 Other
650 _ 7 |a spectral analysis
|2 Other
650 _ 7 |a tissue‐level insights
|2 Other
650 _ 2 |a Spectrum Analysis, Raman: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Microscopy, Confocal: methods
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
700 1 _ |a Zörnig, Inka
|0 P:(DE-He78)e00d6a13ce5ea2af7bde67bac1319dd3
|b 1
|u dkfz
700 1 _ |a Jäger, Dirk
|0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
|b 2
|e Last author
|u dkfz
773 _ _ |a 10.1002/ctm2.70487
|g Vol. 15, no. 10, p. e70487
|0 PERI:(DE-600)2697013-2
|n 10
|p e70487
|t Clinical and translational medicine
|v 15
|y 2025
|x 2001-1326
909 C O |o oai:inrepo02.dkfz.de:304989
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)01ddf9bd69d91bd4b1dbef36f9427f36
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)e00d6a13ce5ea2af7bde67bac1319dd3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-08-08T17:08:03Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-08-08T17:08:03Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-08-08T17:08:03Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-08-08T17:08:03Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2025-01-07
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-07
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-07
920 2 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
920 0 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21